BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 29169740)

  • 1. Redefining Cut-Points for High Symptom Burden of the Global Initiative for Chronic Obstructive Lung Disease Classification in 18,577 Patients With Chronic Obstructive Pulmonary Disease.
    Smid DE; Franssen FME; Gonik M; Miravitlles M; Casanova C; Cosio BG; de Lucas-Ramos P; Marin JM; Martinez C; Mir I; Soriano JB; de Torres JP; Agusti A; Atalay NB; Billington J; Boutou AK; Brighenti-Zogg S; Chaplin E; Coster S; Dodd JW; Dürr S; Fernandez-Villar A; Groenen MTJ; Guimarães M; Hejduk K; Higgins V; Hopkinson NS; Horita N; Houben-Wilke S; Janssen DJA; Jehn M; Joerres R; Karch A; Kelly JL; Kim YI; Kimura H; Koblizek V; Kocks JH; Kon SSC; Kwon N; Ladeira I; Lee SD; Leuppi JD; Locantore N; Lopez-Campos JL; D-C Man W; Maricic L; Mendoza L; Miedinger D; Mihaltan F; Minami S; van der Molen T; Murrells TJ; Nakken N; Nishijima Y; Norman IJ; Novotna B; O'Donnell DE; Ogata Y; Pereira ED; Piercy J; Price D; Pothirat C; Raghavan N; Ringbaek T; Sajkov D; Sigari N; Singh S; Small M; da Silva GF; Tanner RJ; Tsiligianni IG; Tulek B; Tzanakis N; Vanfleteren LEGW; Watz H; Webb KA; Wouters EFM; Xie GG; Yoshikawa M; Spruit MA
    J Am Med Dir Assoc; 2017 Dec; 18(12):1097.e11-1097.e24. PubMed ID: 29169740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-world characterization and differentiation of the Global Initiative for Chronic Obstructive Lung Disease strategy classification.
    Price DB; Baker CL; Zou KH; Higgins VS; Bailey JT; Pike JS
    Int J Chron Obstruct Pulmon Dis; 2014; 9():551-61. PubMed ID: 24920893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GOLD Classification of COPD: Discordance in Criteria for Symptoms and Exacerbation Risk Assessment.
    Mittal R; Chhabra SK
    COPD; 2017 Feb; 14(1):1-6. PubMed ID: 27723367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in classification of COPD group using COPD assessment test (CAT) or modified Medical Research Council (mMRC) dyspnea scores: a cross-sectional analyses.
    Kim S; Oh J; Kim YI; Ban HJ; Kwon YS; Oh IJ; Kim KS; Kim YC; Lim SC
    BMC Pulm Med; 2013 Jun; 13():35. PubMed ID: 23731868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of the new GOLD COPD staging system to a US primary care cohort, with comparison to physician and patient impressions of severity.
    Mapel DW; Dalal AA; Johnson PT; Becker LK; Hunter AG
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1477-86. PubMed ID: 26251587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparisons of health status scores with MRC grades in COPD: implications for the GOLD 2011 classification.
    Jones PW; Adamek L; Nadeau G; Banik N
    Eur Respir J; 2013 Sep; 42(3):647-54. PubMed ID: 23258783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology, severity, and treatment of chronic obstructive pulmonary disease in the United Kingdom by GOLD 2013.
    Raluy-Callado M; Lambrelli D; MacLachlan S; Khalid JM
    Int J Chron Obstruct Pulmon Dis; 2015; 10():925-37. PubMed ID: 25999708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic obstructive pulmonary disease (COPD) assessment test scores corresponding to modified Medical Research Council grades among COPD patients.
    Lee CH; Lee J; Park YS; Lee SM; Yim JJ; Kim YW; Han SK; Yoo CG
    Korean J Intern Med; 2015 Sep; 30(5):629-37. PubMed ID: 26354057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modified Medical Research Council Dyspnea Scale in GOLD Classification Better Reflects Physical Activities of Daily Living.
    Munari AB; Gulart AA; Dos Santos K; Venâncio RS; Karloh M; Mayer AF
    Respir Care; 2018 Jan; 63(1):77-85. PubMed ID: 28874609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Ability of Different Scoring Systems to Predict Mortality in Chronic Obstructive Pulmonary Disease Patients: A Prospective Cohort Study.
    Kim J; Lee CH; Hwang SS; Kim DK; Yoon HI; Lee SH; Kim KU; Kim EK; Kim TH; Lee JH; Oh YM; Lee SD
    Respiration; 2019; 98(6):495-502. PubMed ID: 31665736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discrepancies between modified Medical Research Council dyspnea score and COPD assessment test score in patients with COPD.
    Rhee CK; Kim JW; Hwang YI; Lee JH; Jung KS; Lee MG; Yoo KH; Lee SH; Shin KC; Yoon HK
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1623-31. PubMed ID: 26316736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the assessment of health status between CCQ and CAT in a Chinese COPD clinical population: a cross-sectional analysis.
    Zhou Z; Zhou A; Zhao Y; Duan J; Chen P
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1675-1682. PubMed ID: 29872285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigating sensitivity, specificity, and area under the curve of the Clinical COPD Questionnaire, COPD Assessment Test, and Modified Medical Research Council scale according to GOLD using St George's Respiratory Questionnaire cutoff 25 (and 20) as reference.
    Tsiligianni IG; Alma HJ; de Jong C; Jelusic D; Wittmann M; Schuler M; Schultz K; Kollen BJ; van der Molen T; Kocks JW
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1045-52. PubMed ID: 27274226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of mortality in patients with chronic obstructive pulmonary disease with the new Global Initiative for Chronic Obstructive Lung Disease 2017 classification: a cohort study.
    Gedebjerg A; Szépligeti SK; Wackerhausen LH; Horváth-Puhó E; Dahl R; Hansen JG; Sørensen HT; Nørgaard M; Lange P; Thomsen RW
    Lancet Respir Med; 2018 Mar; 6(3):204-212. PubMed ID: 29331311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between objectively measured physical activity and morning symptoms in COPD.
    van Buul AR; Kasteleyn MJ; Chavannes NH; Taube C
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2831-2840. PubMed ID: 29042764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variation in Assignment of the COPD Patients into a GOLD Group According to Symptoms Severity.
    Moya-Álvarez V; Quevedo-Marín JL; Ji Z; Navarro-Jiménez C; Jiménez-García R; López-de-Andrés A; Pérez-Trullén A; de Miguel-Díez J
    Int J Chron Obstruct Pulmon Dis; 2020; 15():1987-1995. PubMed ID: 32848383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2017 Global Initiative for Chronic Obstructive Lung Disease reclassifies half of COPD subjects to lower risk group.
    Högman M; Sulku J; Ställberg B; Janson C; Bröms K; Hedenström H; Lisspers K; Malinovschi A
    Int J Chron Obstruct Pulmon Dis; 2018; 13():165-173. PubMed ID: 29379281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of symptom burden and adherence to respiratory medications in individuals self-reporting a diagnosis of COPD within a community pharmacy setting.
    Bollmeier SG; Seaton TL; Prosser TR; Chou YT; Reckenberg K; Hahn B; Stanford RH; Ray R
    J Am Pharm Assoc (2003); 2019; 59(4):479-488.e1. PubMed ID: 31126830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New disease severity classification of patients with stable chronic obstructive pulmonary disease in Shanghai.
    Xie G; Zhang Y; Zhou X; ;
    Chin Med J (Engl); 2014; 127(17):3046-50. PubMed ID: 25189943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of Clinical COPD Questionnaire in Patients with COPD: A Cross-Sectional Observational Study.
    Zhou Z; Zhou A; Peng Y; Duan J; Zeng Y; Zhao Y; Cheng W; Chen P
    Respiration; 2020; 99(7):606-616. PubMed ID: 32659763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.